Alouani, E. L., Randrian, V., Elliott, A., Nasir, A., Mieles, D., Abdelfattah, S., Foote, M. B., Maron, S. B., Vlachos, G., Abbass, M., Artz, O., Patel, M., Chatila, W. K., Johannet, P., Mandelker, D., Berger, M. F., Cercek, A., Diaz, L. A., Stadler, Z. K., Rousseau, B. (2026). Clinical impact of
                    <i>MSH3</i>
                    loss-of-function alterations in patients treated with immune checkpoint blockade across cancer types.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.10516